Autologous stem cell transplant and combination immunotherapy of rituximab and interferon ‐α induces prolonged clinical and molecular remissions in patients with follicular lymphoma
Source: British Journal of Haematology - Category: Hematology Authors: Liam Smyth, Rena Buckstein, Nancy Pennell, Rashmi Weerasinghe, Matthew C. Cheung, Kevin Imrie, David Spaner, Eugenia Piliotis, Lisa Chodirker, Marciano Reis, Zeina Ghorab, Liying Zhang, Violet Boudreau, Angela Miliken, Neil Berinstein Tags: Correspondence Source Type: research
More News: Hematology | Immunotherapy | Lymphoma | Rituxan | Stem Cell Therapy | Stem Cells | Transplants | UK Health